Profound Medical (PROF) Return on Sales (2024 - 2026)

Profound Medical's Return on Sales history runs 3 years deep, the most recent figure standing at 0.01% for Q1 2026.

• On a quarterly basis, Return on Sales rose 3.0% year-over-year to 0.01% in Q1 2026; TTM through Mar 2026 was 0.02%, a 2.0% decrease from a year earlier, with the FY2025 full-year figure at 0.03%, down 3.0% from the prior year.
• Return on Sales rose to 0.01% in Q1 2026 per PROF's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Sales topped out at 0.06% in Q4 2024 and bottomed at 0.07% in Q2 2025.
• The 3-year median for Return on Sales is 0.04% (2024), against an average of 0.03%.
• Across the five-year window, Return on Sales slipped 7 bps in 2025 and gained 3 bps in 2026, its largest moves.
• Year by year, Return on Sales stood at 0.06% in 2024, then plunged by 125 bps to 0.01% in 2025, then advanced by 3 bps to 0.01% in 2026.
• Per Business Quant, the three latest PROF Return on Sales figures stand at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.02% (Q3 2025).